Bright Cell, Inc.
Clinical trials sponsored by Bright Cell, Inc., explained in plain language.
-
Could a single infusion restart ovaries in early menopause?
Disease control Not yet recruitingThis early-stage study tests a new drug called YB-1113 for women with premature ovarian insufficiency (early menopause). The goal is to see if it is safe and can help restart ovarian function, potentially allowing women under 40 to become pregnant. Only 6 participants will receiv…
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Stem cells injected into wrinkles: a new Anti-Aging hope?
Symptom relief Not yet recruitingThis early-phase trial tests whether injections of stem cells from umbilical cord tissue can safely reduce moderate to severe nasolabial fold wrinkles (the lines from nose to mouth). Nine adults will receive different doses of BC-101, and researchers will monitor side effects and…
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC